Privia Health Group, Inc. Cash and Equivalents

Quick Answer

Privia Health Group, Inc. reported Cash and Equivalents of $479.69 million for fiscal year 2025.

Privia Health Group, Inc. Cash and Equivalents — Annual History

Fiscal Year Cash and Equivalents YoY Change
2025 $479.69M -2.3%
2024 $491.15M +26.1%
2023 $389.51M +11.9%
2022 $347.99M +8.6%
2021 $320.58M +278.8%
2020 $84.63M

Quarterly Cash and Equivalents

Quarter Ending Cash and Equivalents YoY QoQ
September 30, 2025 $441.35M +4.6% +13.1%
June 30, 2025 $390.13M +0.7% -16.9%
March 31, 2025 $469.33M +33.7% -4.4%
December 31, 2024 $491.15M +26.1% +16.4%
September 30, 2024 $422.00M +27.7% +8.9%
June 30, 2024 $387.35M +21.8% +10.3%
March 31, 2024 $351.14M +12.8% -9.9%
December 31, 2023 $389.51M +11.9% +17.9%
  • Privia Health Group, Inc. showed a decrease of -2.3% in Cash and Equivalents compared to the prior fiscal year.
  • Over the 2020–2025 period, Privia Health Group, Inc.’s cash and equivalents has grown by 466.8% (from $84.63 million to $479.69 million).
  • The most recent figure is from Privia Health Group, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 27, 2026.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment